Cas no 1114543-47-3 (N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide)
N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide Chemical and Physical Properties
Names and Identifiers
-
- 1-((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)-2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole
- N-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl] Rabeprazole Sulfide
- 1-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl]-2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfanyl]benzimidazole
- N-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl] Rabeprazole Sulfide
- 1114543-47-3
- 1-{[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}-2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfanyl)-1H-1,3-benzodiazole
- CS-0166561
- DTXSID80648984
- J-002578
- 1-{[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methyl}-2-({[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methyl}sulfanyl)-1H-benzimidazole
- N-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]rabeprazole sulfide
- 1-((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)-2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole? (Rabeprazole Impurity
- 1-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]-2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole
- G86883
- N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide
-
- Inchi: 1S/C29H36N4O4S/c1-21-24(30-13-11-27(21)36-17-7-15-34-3)19-33-26-10-6-5-9-23(26)32-29(33)38-20-25-22(2)28(12-14-31-25)37-18-8-16-35-4/h5-6,9-14H,7-8,15-20H2,1-4H3
- InChI Key: YULGRACUPORTPS-UHFFFAOYSA-N
- SMILES: S(CC1C(C)=C(C=CN=1)OCCCOC)C1=NC2C=CC=CC=2N1CC1C(C)=C(C=CN=1)OCCCOC
Computed Properties
- Exact Mass: 536.24600
- Monoisotopic Mass: 536.24572682g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 8
- Heavy Atom Count: 38
- Rotatable Bond Count: 15
- Complexity: 664
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 4.4
- Topological Polar Surface Area: 106?2
Experimental Properties
- PSA: 105.82000
- LogP: 5.61430
N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide Security Information
- Signal Word:warning
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:Store at recommended temperature
N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | M265175-50mg |
N-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl] Rabeprazole Sulfide |
1114543-47-3 | 50mg |
$ 190.00 | 2023-09-07 | ||
| TRC | M265175-500mg |
N-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl] Rabeprazole Sulfide |
1114543-47-3 | 500mg |
$ 1478.00 | 2023-09-07 | ||
| A2B Chem LLC | AE15145-50mg |
N-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl] Rabeprazole Sulfide |
1114543-47-3 | 50mg |
$306.00 | 2024-04-20 | ||
| A2B Chem LLC | AE15145-500mg |
N-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl] Rabeprazole Sulfide |
1114543-47-3 | 500mg |
$1556.00 | 2024-04-20 | ||
| SHENG KE LU SI SHENG WU JI SHU | sc-470696-50mg |
N-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl] Rabeprazole Sulfide, |
1114543-47-3 | 50mg |
¥2482.00 | 2023-09-05 | ||
| Biosynth | IM25351-25 mg |
1-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]-2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole |
1114543-47-3 | 25mg |
$144.50 | 2023-01-04 | ||
| Biosynth | IM25351-50 mg |
1-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]-2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole |
1114543-47-3 | 50mg |
$262.50 | 2023-01-04 | ||
| Biosynth | IM25351-100 mg |
1-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]-2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole |
1114543-47-3 | 100MG |
$477.00 | 2023-01-04 | ||
| Biosynth | IM25351-250 mg |
1-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]-2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole |
1114543-47-3 | 250MG |
$872.50 | 2023-01-04 | ||
| Biosynth | IM25351-500 mg |
1-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]-2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole |
1114543-47-3 | 500MG |
$1,580.00 | 2023-01-04 |
N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide Related Literature
-
Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
-
Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
-
5. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
Additional information on N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide
N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide (CAS 1114543-47-3): A Comprehensive Overview
N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide (CAS 1114543-47-3) is a specialized chemical compound with significant relevance in pharmaceutical research and development. This compound, often referred to as a key intermediate in the synthesis of Rabeprazole derivatives, has garnered attention due to its potential applications in medicinal chemistry. In this article, we delve into the properties, synthesis, applications, and market trends of this compound, while addressing common queries and industry trends.
The molecular structure of N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide features a pyridine ring substituted with a methoxypropoxy group and a methyl group, which contributes to its unique chemical behavior. Researchers often explore this compound for its role in developing proton pump inhibitors (PPIs), a class of drugs widely used to treat acid-related gastrointestinal disorders. The CAS 1114543-47-3 identifier ensures precise identification in scientific literature and regulatory documentation.
One of the most frequently searched questions about this compound is: "What is the role of N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide in drug synthesis?" The answer lies in its function as a precursor in the production of Rabeprazole, a well-known PPI. The sulfide moiety in this intermediate can be further oxidized to the corresponding sulfoxide, a critical step in the synthesis of the active pharmaceutical ingredient (API). This process highlights the compound's importance in the pharmaceutical manufacturing pipeline.
Recent advancements in green chemistry have also sparked interest in the synthesis of N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide. Researchers are exploring eco-friendly catalysts and solvent-free conditions to improve the sustainability of its production. This aligns with the growing demand for environmentally responsible pharmaceutical processes, a topic frequently discussed in scientific forums and industry conferences.
The analytical characterization of CAS 1114543-47-3 typically involves techniques such as nuclear magnetic resonance (NMR) spectroscopy, high-performance liquid chromatography (HPLC), and mass spectrometry (MS). These methods ensure the purity and identity of the compound, which is crucial for its intended applications. Quality control protocols for this intermediate adhere to stringent pharmacopeial standards, reflecting its significance in drug development.
Market trends indicate a steady demand for N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide, driven by the increasing prevalence of gastrointestinal disorders and the need for effective PPIs. Pharmaceutical companies are investing in scalable synthesis routes to meet this demand while maintaining cost efficiency. Additionally, the compound's potential use in novel drug formulations is an area of active research, with studies exploring its derivatives for enhanced therapeutic effects.
In conclusion, N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide (CAS 1114543-47-3) is a vital intermediate in pharmaceutical chemistry, with applications spanning drug synthesis and beyond. Its unique structural features, combined with ongoing research into sustainable production methods, position it as a compound of enduring interest. For researchers and industry professionals, understanding its properties and market dynamics is essential for leveraging its full potential.
1114543-47-3 (N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfide) Related Products
- 1246818-79-0(N-4-(3-Methoxypropoxy)-3-methyl-2-pyridinylmethyl Rabeprazole Sulfone)
- 1083100-27-9(N-3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinylmethyl Lansoprazole Sulfide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)